Patient advocate offers a sanctuary for loved ones to gather and rest
Families who fight cancer along with their ailing loved one grapple with many issues, from health decisions and a myriad of emotions to logistical and […]
Families who fight cancer along with their ailing loved one grapple with many issues, from health decisions and a myriad of emotions to logistical and […]
Since Christopher A. Fausel, PharmD, MHA, BCOP, was appointed as Chairman of the Board of Directors for Hoosier Cancer Research Network in July 2013, he […]
A Hoosier Cancer Research Network study is testing a treatment combination for patients with gastric or esophageal cancer. The phase II study, HCRN GI17-319, focuses […]
A Hoosier Cancer Research Network study for patients with high-risk ocular melanoma, a rare type of cancer affecting the eye, is now open for accrual. […]
Researchers participating in GI14-186, a Hoosier Cancer Research Network study for patients with metastatic colorectal cancer (mCRC), recently reported their findings in the journal Cancer […]
A Hoosier Cancer Research Network trial, HCRN-LUN18-357, titled “P1.08D.03 Induction Durvalumab Followed by Chemoradiation and Consolidation Durvalumab for Stage III Non-Small Cell Lung Cancer (NSCLC)” […]
Randomized Phase II Trial of Single Agent Chemotherapy Plus Nivolumab or Single Agent Chemotherapy Alone in Patients With Advanced Squamous, Non-squamous or Not Otherwise Specified […]
A Phase II Study of Single Agent Gemcitabine In Relapsed or Refractory Follicular or Small Lymphocytic Non-Hodgkin’s Lymphoma
Hoosier Cancer Research Network is happy to celebrate the research accomplishments of our members over the past year. Congratulations to all researchers and study […]
Next Meeting See HCRN Calendar for schedule. Working Group Members Patrick Boland, MD (co-chair) — Rutgers University Richard Kim, MD (co-chair) — Moffitt Cancer Center […]
A new Hoosier Cancer Research Network clinical trial studying Merkel cell carcinoma is currently recruiting subjects. The trial, A Single Arm Phase II Study with […]
A phase II single arm multi-center trial evaluating the efficacy of pembrolizumab in the treatment of patients with incurable platinum refractory germ cell tumors.
Next Meeting See HCRN Calendar for schedule. Working Group Members Gaorav Gupta, MD, PhD (co-chair) — University of North Carolina David J. McConkey, PhD (co-chair) […]
A Phase II Trial of Atezolizumab plus Chemotherapy after Progression on Single Agent PD-1 or PD-L1 Inhibitor in Cisplatin-ineligible Patients with Advanced Urothelial Carcinoma
A Multi-Center, Single Arm, Phase II study of Pembrolizumab (MK-3475) in Combination with Chemotherapy for Patients with Advanced Colorectal Cancer: HCRN GI14-186
The American Society of Clinical Oncology’s ASCO20 Virtual Scientific Program will feature abstracts from three Hoosier Cancer Research Network studies. The program, taking place May […]
PhAse I/II StuDy of Modern ImmunotherApy in BCG-RelaPsing UroThelial Carcinoma of the BLADDER – (ADAPT-BLADDER) HCRN GU16-243 Status: Open to Accrual
David J. McConkey, PhD (pictured left), professor of urology and oncology at The Johns Hopkins University School of Medicine, and Gaorav P. Gupta, MD, PhD, […]
A Phase 2 Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer (CANOPY) Status: Open to Accrual
Investigators participating in Hoosier Cancer Research Network’s Thoracic Clinical Trial Working Group have named three of their colleagues to serve as co-chairs of the group. […]
Facebook
Hoosier Cancer Research Network on Facebook
Linked In
You Tube
Twitter